BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20143334)

  • 1. Profilin-1 overexpression inhibits proliferation of MDA-MB-231 breast cancer cells partly through p27kip1 upregulation.
    Zou L; Ding Z; Roy P
    J Cell Physiol; 2010 Jun; 223(3):623-9. PubMed ID: 20143334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial morphological reversion drives Profilin-1-induced elevation of p27(kip1) in mesenchymal triple-negative human breast cancer cells through AMP-activated protein kinase activation.
    Jiang C; Veon W; Li H; Hallows KR; Roy P
    Cell Cycle; 2015; 14(18):2914-23. PubMed ID: 26176334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profilin-1 overexpression upregulates PTEN and suppresses AKT activation in breast cancer cells.
    Das T; Bae YH; Wells A; Roy P
    J Cell Physiol; 2009 Feb; 218(2):436-43. PubMed ID: 18937284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
    Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profilin-1 overexpression restores adherens junctions in MDA-MB-231 breast cancer cells in R-cadherin-dependent manner.
    Zou L; Hazan R; Roy P
    Cell Motil Cytoskeleton; 2009 Dec; 66(12):1048-56. PubMed ID: 19593789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.
    Coumans JV; Gau D; Poljak A; Wasinger V; Roy P; Moens PD
    OMICS; 2014 Dec; 18(12):778-91. PubMed ID: 25454514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis.
    Ding Z; Joy M; Bhargava R; Gunsaulus M; Lakshman N; Miron-Mendoza M; Petroll M; Condeelis J; Wells A; Roy P
    Oncogene; 2014 Apr; 33(16):2065-74. PubMed ID: 23686314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness.
    Zou L; Jaramillo M; Whaley D; Wells A; Panchapakesa V; Das T; Roy P
    Br J Cancer; 2007 Nov; 97(10):1361-71. PubMed ID: 17940506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profilin-1 deficiency leads to SMAD3 upregulation and impaired 3D outgrowth of breast cancer cells.
    Chakraborty S; Jiang C; Gau D; Oddo M; Ding Z; Vollmer L; Joy M; Schiemann W; Stolz DB; Vogt A; Ghosh S; Roy P
    Br J Cancer; 2018 Oct; 119(9):1106-1117. PubMed ID: 30318519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-24-3p promotes cell proliferation and inhibits apoptosis in human breast cancer by targeting p27Kip1.
    Lu K; Wang J; Song Y; Zhao S; Liu H; Tang D; Pan B; Zhao H; Zhang Q
    Oncol Rep; 2015 Aug; 34(2):995-1002. PubMed ID: 26044523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A balanced level of profilin-1 promotes stemness and tumor-initiating potential of breast cancer cells.
    Jiang C; Ding Z; Joy M; Chakraborty S; Kim SH; Bottcher R; Condeelis J; Singh S; Roy P
    Cell Cycle; 2017; 16(24):2366-2373. PubMed ID: 28699810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization and Ser-137 phosphorylation regulate tumor-suppressive activity of profilin-1.
    Diamond MI; Cai S; Boudreau A; Carey CJ; Lyle N; Pappu RV; Swamidass SJ; Bissell M; Piwnica-Worms H; Shao J
    J Biol Chem; 2015 Apr; 290(14):9075-86. PubMed ID: 25681442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus expressing mutant p27kip1 enhanced apoptosis and inhibited the growth of xenografted human breast cancer.
    Sasaki T; Katayose Y; Yamamoto K; Mizuma M; Shiraso S; Yabuuchi S; Oda A; Rikiyama T; Oikawa M; Onogawa T; Suzuki M; Lee CT; Unno M
    Surg Today; 2007; 37(12):1073-82. PubMed ID: 18030569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing profilin-1 inhibits gastric cancer progression via integrin β1/focal adhesion kinase pathway modulation.
    Cheng YJ; Zhu ZX; Zhou JS; Hu ZQ; Zhang JP; Cai QP; Wang LH
    World J Gastroenterol; 2015 Feb; 21(8):2323-35. PubMed ID: 25741138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propofol induces apoptosis of breast cancer cells by downregulation of miR-24 signal pathway.
    Yu B; Gao W; Zhou H; Miao X; Chang Y; Wang L; Xu M; Ni G
    Cancer Biomark; 2018 Feb; 21(3):513-519. PubMed ID: 29103019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of profilin-1 expression enhances breast cancer cell motility by Ena/VASP proteins.
    Bae YH; Ding Z; Zou L; Wells A; Gertler F; Roy P
    J Cell Physiol; 2009 May; 219(2):354-64. PubMed ID: 19115233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch3 overexpression causes arrest of cell cycle progression by inducing Cdh1 expression in human breast cancer cells.
    Chen CF; Dou XW; Liang YK; Lin HY; Bai JW; Zhang XX; Wei XL; Li YC; Zhang GJ
    Cell Cycle; 2016; 15(3):432-40. PubMed ID: 26694515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
    Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P
    J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.
    Cornelissen B; Kersemans V; McLarty K; Tran L; Vallis KA; Reilly RM
    Nucl Med Biol; 2009 Oct; 36(7):811-9. PubMed ID: 19720293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.